Press

Filter by tags
In Astounding Test, Scientists Revive Damaged Lungs for Transplant

In Astounding Test, Scientists Revive Damaged Lungs for Transplant

Injured and unusable lungs were restored with respirators and pig blood.  The procedure one day may increase the supply of organs for transplant.
Xenogeneic Cross-Circulation for Extracorporeal Recovery of Injured Human Lungs

Xenogeneic Cross-Circulation for Extracorporeal Recovery of Injured Human Lungs

Here we demonstrate that acutely injured human lungs declined for transplantation, including a lung that failed to recover on EVLP, can be recovered by cross-circulation of whole blood between explanted human lungs and a Yorkshire...
How to use a live pig to revitalize a human lung

How to use a live pig to revitalize a human lung

Unusual method could increase the supply of lungs available for transplantation.
Xylyx Bio releases advanced disease model system to improve cancer drug discovery

Xylyx Bio releases advanced disease model system to improve cancer drug discovery

The IN SITE™ Metastasis Kit provides key features of the cancer microenvironment to increase predictiveness and improve decision making in development of anti-cancer drugs
Multiday Maintenance of Extracorporeal Lungs Using Cross-Circulation With Conscious Swine

Multiday Maintenance of Extracorporeal Lungs Using Cross-Circulation With Conscious Swine

Lung remains the least-utilized solid organ for transplantation. Efforts to recover donor lungs with reversible injuries using ex vivo perfusion systems are limited to <24 hours of support. Here, we demonstrate the feasibility of extending normothermic extracorporeal...
Evolving Tools for Accelerating 3D Cell Culture Workflows

Evolving Tools for Accelerating 3D Cell Culture Workflows

While the primary benefit of 3D cell cultures—greater resemblance to in vivo conditions than their 2D counterparts—is undoubtedly valuable in physiological research, 3D cultures are still more difficult to use compared to 2D cultures. But...
Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening

Xylyx Bio announces development of disease-specific cell culture products to accelerate anti-fibrotic drug discovery and screening

Fibrosis-specific substrates provide a disease-relevant in-vitro testing platform to inform decision-making in early-stage drug discovery
Xylyx Bio joins Advanced Regenerative Manufacturing Institute (ARMI) Consortium

Xylyx Bio joins Advanced Regenerative Manufacturing Institute (ARMI) Consortium

Xylyx Bio to focus on accelerating the standardization and commercialization of tissue-specific extracellular matrix biomaterials for regenerative medicine and tissue engineering
Cell culture with all the comforts of home

Cell culture with all the comforts of home

By overlooking physiologic components of the extracellular environment, researchers risk obtaining misleading or irreproducible results in the critical early stages of drug discovery and development.